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Transcriptomic profiling of bovine IVF embryos
revealed candidate genes and pathways involved
in early embryonic development
Wen Huang1, Brian S Yandell2, Hasan Khatib1*
Abstract
Background: Early embryonic loss is a large contributor to infertility in cattle. Although genetic factors are known
to affect early embryonic development, the discovery of such factors has been a serious challenge. The objective
of this study was to identify genes differentially expressed between blastocysts and degenerative embryos at early
stages of development.
Results: Using microarrays, genome-wide RNA expression was profiled and compared for in vitro fertilization (IVF) -
derived blastocysts and embryos undergoing degenerative development up to the same time point. Surprisingly
similar transcriptomic profiles were found in degenerative embryos and blastocysts. Nonetheless, we identified 67
transcripts that significantly differed between these two groups of embryos at a 15% false discovery rate, including
33 transcripts showing at least a two-fold difference. Several signaling and metabolic pathways were found to be
associated with the developmental status of embryos, among which were previously known important steroid
biosynthesis and cell communication pathways in early embryonic development.
Conclusions: This study presents the first direct and comprehensive comparison of transcriptomes between IVF
blastocysts and degenerative embryos, providing important information for potential genes and pathways
associated with early embryonic development.
Background
The decline in reproductive efficiency in high producing
dairy cows has become a worldwide challenge to the
dairy industry and scientific community [1]. Successful
fertilization and normal embryonic development are two
main components of fertility. There is a growing con-
cern about early embryonic loss, which accounts for a
large proportion of infertility, particularly in high-produ-
cing cows [2]. Moreover, the bovine has become an
increasingly popular animal model for studying develop-
ment of human embryos because of similar biochemical
processes in these species [3,4]. However, little has been
understood concerning the mechanisms underlying
proper early embryonic development in cattle.
Genome-wide expression profiling by microarrays has
proved a highly effective tool for high throughput
analysis of transcriptomes of tissues, cell lines, or any
biological mRNA pools, usually across different stages,
conditions, or treatments. Indeed, a number of studies
have utilized microarrays to understand the dynamics of
gene expression during early embryonic development.
For example, Misirlioglu et al. [5] and Kues et al. [6]
investigated the dynamics of gene expression and
defined subsets of genes regulated during preimplanta-
tion development of bovine embryos, particularly those
related to embryonic genome activation. In addition,
using a cDNA microarray consisting of 932 bovine
ESTs, between in vitro- and in vivo-cultured blastocysts
of varying quality, Corcoran et al. [7] were able to iden-
tify 384 differentially-expressed genes that were believed
to affect subsequent survival and pregnancy. However,
no study has directly investigated changes in gene
expression associated with abnormal early embryonic
development or growth retardation of embryos.
An in vitro fertilization (IVF) system has been previously
established in our laboratory to identify genetic markers for
* Correspondence: hkhatib@wisc.edu
1Department of Dairy Science, University of Wisconsin-Madison, Madison,
WI 53706, USA
Huang et al. BMC Genomics 2010, 11:23
http://www.biomedcentral.com/1471-2164/11/23
© 2010 Huang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
fertility traits in cattle [8-10]. Specifically, the developmental
status of embryos is graded based on their morphology. In
contrast to blastocysts, degenerative embryos appear mor-
phologically retarded in their development. These embryos
do not exhibit a distinct inner cell mass and have no blasto-
coele. Using this system, single nucleotide polymorphisms
in several genes have been shown to be associated with fer-
tilization and blastocyst rates [8-10]. The aim of this study
was to characterize transcriptomic differences between IVF
blastocysts and degenerative embryos. This is the first
direct and comprehensive comparison between in vitro-
produced embryos with distinct morphological phenotypes.
Although remarkably similar gene expression profiles were
found between blastocysts and degenerative embryos, a
total of 67 differentially expressed transcripts were identi-
fied. Results of this study may help elucidate transcriptomic
changes associated with abnormal development in mam-
malian species and facilitate improvement of assisted repro-
ductive technologies.
Results
Global transcriptomic changes in degenerative embryos
compared to blastocysts
In order to characterize global transcriptomic changes of
degenerative embryos concurrent with their abnormal
embryonic development, a comparative microarray experi-
ment was designed. Because the amount of RNA present
in a single embryo is rather limited, three independent
pools each consisting of 20 embryos were constructed for
blastocysts and degenerative embryos (Figure 1). Total
RNA was extracted from each pool of embryos and sub-
jected to linear amplification [11] before standard microar-
ray labeling and hybridization were performed on a
GeneChip Bovine Genome Array [12]. A total of 14,509
and 14,411 transcripts were detected as expressed in blas-
tocysts and degenerative embryos, respectively. Interest-
ingly, Pearson’s correlation between averaged gene
expression of blastocysts and degenerative embryos was
0.986, suggesting a high similarity between their gene
expression profiles. To visualize transcriptomic changes
with respect to physical locations, change in gene expres-
sion of degenerative embryos as compared to blastocysts
was plotted along each chromosome (Figure 2). Notably,
the majority of transcripts showed little or no difference
between blastocysts and degenerative embryos. In addition,
differentially expressed genes scattered across all chromo-
somes without any apparent pattern. Taken together, these
results suggest that although there were distinct phenoty-
pic outcomes, little change had occurred in the transcrip-
tome of degenerative embryos as compared to blastocysts.
Identification and clustering of differentially
expressed genes
Although there was little change to the global transcrip-
tome of degenerative embryos, significance analysis of
microarrays (SAM) identified 67 (false discovery rate
(FDR) = 0.15) transcripts differentially expressed between
blastocysts and degenerative embryos, of which 33 showed
at least a two-fold difference (Table 1). Among these 33
differentially-expressed transcripts, three were upregulated
in degenerative embryos whereas the remaining transcripts
were downregulated. In order to validate the microarray
results, PHLDA2, FERMT2, RP2, SHISA2, MCF2L,
TGFBR3, SLC11A2, SERPINC1 and FDFT1 were chosen
for quantitative gene expression using real-time RT-PCR
(see Methods for gene selection criteria). Different sources
of RNA were used to accomplish biological replications.
For PHLDA2, FERMT2, RP2, and SHISA2, we carried out
real-time RT-PCR in the same amplified RNA (aRNA)
samples used for microarrays as well as RNA samples from
four independently constructed embryo pools (Additional
file 1). For the remaining five genes, another independent
set of six RNA pools (three for each of blastocysts and
degenerative embryos) were used. Importantly, although
magnitude and variability of fold change differed slightly
between the different sources of RNA and quantitation
methods (microarray and real-time RT-PCR), the same
trends observed in the microarrays were also observed in
Figure 1 Examples of morphological stage grading used in this
study. Putative zygotes were cultured until day 5, when embryos
were examined for evidence of compaction. Embryos that showed
compaction by this time were classified as compacted morula (A)
while embryos that did not exhibited compaction or attained 16-32
cells were classified as “early degenerative” (B). Compacted morulas
were further cultured until day 8 when they were evaluated for
presence of blastocoele. Embryos that showed distinct inner cell
mass and blastocoele were classified as “blastocysts” (C) and
embryos that did not properly complete transition from morula to
blastocyst were classified as “late degenerative” (D). Transcriptomic
profiles of blastocysts (C) and late degenerative embryos (D) were
compared in this study.
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the real-time RT-PCR. For eight of the nine examined
genes, expression differences between degenerative
embryos and blastocysts were confirmed in the real-time
RT-PCR (Figure 3), underscoring the validity of our experi-
mental procedures and data analysis. For example,
PHLDA2 was upregulated eight-fold in degenerative
embryos as observed with microarray whereas real-time
RT-PCR using unamplified mRNA detected a six-fold
upregulation. Nonetheless, different sensitivity and bias
were expected for different quantitation methods. The
exception to microarray confirmation by real-time RT-
PCR was MCF2L, a gene whose variability in expression
was notably high. In degenerative embryos, MCF2L
appeared to be downregulated in the microarray results yet
appeared upregulated in the real-time RT-PCR analysis.
To qualitatively explore patterns of co-regulation of the
67 differentially-expressed genes [13], expression profiles
of these genes were clustered and visualized in a heat-
map (Figure 4). Notably, FERMT2 (MIG2), RAP1A, and
TJP1 (ZO1) showed closely clustered expression levels
and patterns, and all of them have been shown to be
involved in a pathway related to cell adhesion functions
[14-16], suggesting that at least for this signaling path-
way, systematic expression alteration had occurred in
degenerative embryos compared to blastocysts.
Signaling pathways associated with abnormality
of embryonic development
To further understand transcriptomic changes that have
occurred in degenerative embryos at a systems level,
Gene Set Enrichment Analysis (GSEA) [17] and gene
ontology (GO) enrichment analysis were carried out.
GSEA identifies a priori defined signaling pathways
whose member genes show expression correlated with
developmental status of embryos. A collection of 649
signaling pathways in the MsigDB database curated
from various sources [17] were interrogated. GSEA at
25% FDR revealed five pathways enriched in degenera-
tive embryos and four pathways enriched in blastocysts
(Table 2). In addition, GO terms were also tested for
overrepresentation in differentially expressed genes
using a hypergeometric test, and five GO terms were
significant at 25% FDR (Table 2). Remarkably, both
GSEA and GO enrichment pointed to a significant asso-
ciation of steroid biosynthesis and cell communication
(‘Small GTPase mediated signal transduction’ is a child
of the GO term ‘cell communication’) processes with
developmental status (Table 2). This evidence strongly
suggested involvement of these pathways in abnormal
embryonic development.
Discussion
In the present study we report the transcriptomic profil-
ing of blastocysts and degenerative embryos and identifi-
cation of candidate genes and pathways involved in early
embryonic development. While global gene expression
in blastocysts and degenerative embryos was largely
similar, 67 (33 with greater than 2 fold difference) tran-
scripts were significantly different between these two
groups of embryos. In addition, several signaling path-
ways were found to be altered in degenerative embryos
Figure 2 Global change in transcriptomes of degenerative embryos. Differences between the mean log2 transformed expressions of
degenerative embryos and blastocysts plotted along each chromosome. 18 transcripts on the “Y” chromosome could not be plotted because
there was no physical location information available for the “Y” chromosome from the current genome assembly. Each vertical bar on the
chromosomes represents one transcript and was colored according to the expression difference. Bars above the axis were transcripts on the
forward strand while bars below the axis were transcripts on the reverse strand. Blue color represents lower expression in degenerative embryos
compared with blastocysts while red color represents higher expression in degenerative embryos, as indicated by the scale bar on the right.
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as compared to blastocysts. Although there has been a
number of reports on dynamics of transcriptomes in
IVF embryos [5,6], this study, to the best of our knowl-
edge, reports the first direct and comprehensive com-
parison between blastocysts and degenerative embryos
produced by IVF. We believe transcriptomic alteration
characterized through this comparison could provide
insights into mechanisms of early embryonic develop-
ment and may help identify biomarkers for growth
defect in IVF and for infertility in cattle.
Validity of the experimental design
and microarray analysis
Pooling of embryos and amplification of RNA in this
study were necessitated by scarcity of RNA present in
embryos [5,6]. These approaches have been well docu-
mented in the literature [5,18,19]. In this study, we
pooled a relatively large number (n = 20) of independent
embryos in each pool to achieve a sufficient accuracy of
biological pooling. In order to validate the results of
microarray experiment and analysis, a total of 16
Table 1 Transcripts differentially expressed by at least two-fold in degenerative embryos as compared to blastocysts
(FDR <= 0.15)
Gene symbol1 Gene name Fold change P value2
Upregulated
PHLDA2 pleckstrin homology-like domain, family A, member 2 8.18 0.00002
LOC540268 hypothetical LOC540268 4.19 0.00008
C14H8ORF70 chromosome 8 open reading frame 70 ortholog 3.01 0.00017
Downregulated
CMBL carboxymethylenebutenolidase homolog (Pseudomonas) 2.16 0.00004
CTNS cystinosis, nephropathic 2.09 0.00005
TNNC2 troponin C type 2 (fast) 3.47 0.00015
TGFBR3 transforming growth factor, beta receptor III 2.22 0.00022
DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides 3.01 0.00024
FERMT2 fermitin family homolog 2 (Drosophila) 2.07 0.00026
PECR peroxisomal trans-2-enoyl-CoA reductase 2.14 0.00031
SLC11A23 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 2.33 0.00035
Bt.19510.2.A1_at transcribed locus 2.33 0.00036
Bt.21611.1.S1_at transcribed locus 2.32 0.00037
SHISA2 shisa homolog 2 (Xenopus laevis) 2.54 0.00039
Bt.22693.1.A1_at transcribed locus 7.31 0.00042
MGC157372 hypothetical LOC614796 2.34 0.00046
MCF2L MCF.2 cell line derived transforming sequence-like 4.32 0.00050
SLC10A1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 12.67 0.00055
SERPINC1 serpin peptidase inhibitor, clade C (antithrombin), member 1 2.23 0.00058
CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide 1 2.14 0.00063
Bt.6523.1.A1_at transcribed locus 2.49 0.00077
LOC521943 similar to hCG1788238 3.41 0.00078
SLC11A23 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 2.19 0.00079
Bt.17542.1.S1_at transcribed locus 2.43 0.00081
Bt.27347.1.A1_at transcribed locus 3.05 0.00082
PTPRK protein tyrosine phosphatase, receptor type, K 4.04 0.00087
Bt.19644.1.A1_at transcribed locus 3.20 0.00088
FDFT1 farnesyl-diphosphate farnesyltransferase 1 2.52 0.00089
CYP51 cytochrome P450, family 51, subfamily A, polypeptide 1 3.48 0.00094
RP2 retinitis pigmentosa 2 (X-linked recessive) 4.41 0.00095
LOC790609 similar to aminoacylase 1 2.45 0.00098
LOC513587 similar to UPF0474 protein C5orf41 4.33 0.00116
SLC25A21 solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 2.75 0.00119
1 Transcripts without annotations were identified by probe set ID.
2 Raw p values from significance analysis of microarray (SAM), transcripts were ordered according to their p values.
3 The gene SLC11A2 is represented by multiple probe sets on the Bovine Genome Array.
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different pools (eight for each of blastocysts and degen-
erative embryos) from two different sources of RNA
were used as biological replications in the real-time RT-
PCR experiments (Figure 3 and Additional File 1).
Importantly, eight out of the nine differentially-
expressed genes identified through the microarray
experiment and SAM were validated in real-time RT-
PCR, testifying to the validity of the experimental design
and the analysis used in this study.
It is possible that some of the degenerative embryos
could be in different developmental stages because of
the three-day time window of embryo collection. How-
ever, we prefer not to narrow down this window into
one or two days because shorter times would result in
substantial disturbance to embryo culture and mischar-
acterization of the two groups of embryos. Thus, we
assume that there is some variation in gene expression
within the degenerative embryos and that this variation
would be reduced by pooling the embryos for expression
analysis. Poor synchronization of embryos and integrity
of RNA extracted from embryos could potentially intro-
duce errors to the experiment. RNA integrity was
checked before every major step in the microarray
experiment to ensure sample quality. Moreover,
although pooling of embryos removes variation between
individual embryos from expression measurements, cor-
relations between gene expression of pools can be used
to assess synchronization in the same group of embryos
and identify outliers due to compromise of RNA integ-
rity. In fact, correlations of gene expression between
samples were 0.979-0.995 within the group of blasto-
cysts and 0.951-0.990 among degenerative embryos.
This is an evidence of synchronization and integrity of
the biological samples used in this study.
A comparison between gene expression profiles of
embryos in this study with embryos at the same devel-
opmental stage from other studies would also indicate
whether RNA and data quality was compromised in our
samples. In fact, high correlations between gene expres-
sion profiles of our samples and those of Kues et al. [6]
using the same microarray platform were observed. The
correlations between our IVF blastocysts and those of
Kues at al. were 0.942-0.970, and the correlations
between our degenerative embryos and IVF blastocysts
of Kues et al. were 0.925-0.957. Collectively, these
results suggest that blastocysts and degenerative
embryos used in the present study were largely synchro-
nized to the same stage.
Biologically sensible results
We identified 67 differentially-expressed transcripts and
several candidate pathways associated with abnormal
early embryonic development. The identification of pre-
viously known candidate genes or pathways is also an
important aspect of microarray experiments. Interest-
ingly, a number of genes and pathways identified in this
study fall into this category of biologically sensible
results. PHLDA2 (also known as TSSC3) was found to
be upregulated in degenerative compared to blastocysts
by both microarray and real-time RT-PCR (Table 1 and
Figure 3). PHLDA2 is an apoptosis-related gene that
maps to a paternally-imprinted region involved in can-
cer development [20]. The imprinting status of bovine
PHLDA2 is not yet known. However, two known
imprinted genes H19 and IGF2 are located nearby on
bovine chromosome 29 [21,22], and the whole con-
served cluster is imprinted in human and mouse [20,23].
Interestingly, overexpression of PHLDA2 in mice caused
placental growth retardation [24] while PHLDA2 knock-
out mice showed placental overgrowth [25], indicating
that proper PHLDA2 expression is required for normal
placental growth. Thus, our result offers further support
for the importance of tightly regulated expression of
PHLDA2 and may indicate its involvement in earlier
stages of development.
Another differentially-regulated gene in degenerative
embryos versus blastocysts is TGFBR3, one of the three
types of receptors for TGF beta and one that regulates
ligand binding of TGF beta to type I and type II receptors
[26]. In addition, although not meeting our FDR cutoff,
Figure 3 Real-time RT-PCR validation of microarray results. All
expressions were normalized to GAPDH in the same RNA sample,
analyzed by the 2-ΔΔCt method [44]. Data is shown as (Mean +/-
SEM) fold changes. Upregulation in degenerative embryos is
represented by bars above the x axis while downregulation in
degenerative embryos is represented by bars below the x axis. For
genes PHLDA2, FERMT2, RP2, and SHISA2, real-time RT-PCR was
carried out in three amplified aRNA samples and two unamplified
mRNA samples for each of blastocysts and degenerative embryos
(Additional file 1). For genes MCF2L, TGFBR3, SLC11A2, SERPINC1, and
FDFT1, real-time RT-PCR was performed in a different set of three
unamplified mRNA samples for each of blastocysts and
degenerative embryos (Additional file 1).
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the TGF beta signaling pathway was significantly (p =
0.046) associated with the developmental status of
embryos. Collectively, these two lines of evidence suggest
an important role of TGF beta signaling pathway in nor-
mal embryonic development, which has been reported in
other studies [27]. Cell communication and steroid bio-
synthesis pathways identified by both GSEA and GO
enrichment analyses are of particular interest (Table 2)
and their roles in early embryonic development have
been studied extensively. For example, gap junctions and
cell communication have been well documented to have
profound influence on early embryonic development
[28,29], while several steroid hormones are required for
transition from morula into blastocyst stage [30,31].
Small change, large effect
Although the phenotypic outcomes of degenerative
embryos and blastocysts were distinct, we did not
observe dramatic transcriptomic changes differentiating
these two groups of embryos. The correlation between
gene expression of blastocysts and degenerative embryos
Figure 4 Clustering of expression of candidate genes involved in early embryonic development. Expression levels for 67 differentially
expressed genes for the six samples were hierarchically clustered and shown in a heatmap. Level of expression was represented by color scale
from green (low) to red (high), as indicated by a scale bar in the upper left corner. Dendrograms of distances were also shown for genes (left)
and samples (top). Names of samples and genes were indicated on the bottom and right, respectively. For genes without annotation, probe set
IDs were shown.
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was relatively high (r = 0.986). Among the 67 differen-
tially- expressed transcripts, 33 were changed by more
than two fold while only eight of them differed by more
than four-fold, and two of them by eight-fold. One may
argue that the sample size in this study is not large
enough to detect small changes, so that many genuine
differentially-expressed genes were missed. This is true
for most microarray experiments, which normally do
not involve many samples. However, our pooling strat-
egy that reduces variation between samples presumably
should alleviate this problem. Indeed, about half (34/67)
of the differentially-expressed genes were less than two-
fold different. These results suggest that small transcrip-
tomic changes can lead to the distinct phenotype
observed in the degenerative embryos and that the high
degree of similarity observed between degenerative
embryos and blastocysts was a results of true effects
rather than of insufficient experimental power.
The ability to detect differentially expressed genes can
also be limited by completeness of transcripts manufac-
tured on the microarray platform. The Affymetrix Bovine
Genome Array has 24,128 probe sets representing over
23,000 bovine transcripts. Contents of the array were
based on GenBank and UniGene databases. Although it
is possible that some transcripts exclusively expressed
during early development are not represented on the
array, it is unlikely that too many transcripts are missed.
The size of the differences in expression may be a spe-
cific characteristic of these genes, yet small changes in
gene expression can lead to pronounced phenotypic
change. For example, silencing by microRNAs has been
shown to be less than two-fold [32,33], yet they have
been suggested to regulate a wide range of developmen-
tal processes to a large degree. Thus, our results suggest
that small transcriptomic changes could lead to the
abnormal development of degenerative embryos.
Influence of in vitro culture
There have been several reports comparing genome
wide mRNA profiles between IVF and in vivo blasto-
cysts [7,34]. These studies demonstrated that expres-
sions of a number of genes were changed in IVF
blastocysts as compared to embryos produced in vivo.
Identification of genes affecting quality of IVF embryos
due to culture system is undoubtedly important. Never-
theless, comparison between blastocysts and degenera-
tive embryos in this study is also important because
only 30%-35% zygotes can successfully develop to blas-
tocyst stage in vitro, a large source of economic loss.
There are likely to be various reasons for unsuccessful
development in vitro but genetics seems to play an
important role [8,10]. Embryos cultured in vitro are in a
unified environment; therefore significant differential
expressions detected are likely to be associated with
developmental defect rather than culture system. In fact,
we compared our list of differentially expressed genes to
the 200 genes that showed expression differences
between IVF embryos and embryos produced in vivo by
artificial insemination [34]. Importantly, among the 67
differentially expressed genes identified in our study,
only one gene (DAPP1) showed in vitro/in vivo differ-
ence [34]. This result suggests that the differentially
expressed genes identified in this study were likely due
to developmental defect rather than culture system.
Conclusions
In summary, we found that the transcriptome of degen-
erative embryos was largely unchanged as compared to
their blastocysts counterparts, yet there was a relatively
small number of candidate genes that displayed differen-
tial expression between the two groups of embryos. We
also found several signaling and metabolic pathways
associated with bovine early embryonic development.
Table 2 Gene Set Enrichment Analysis (GSEA) and GO enrichment analysis results with FDR = 0.25
GSEA pathways Sample
size (n/m)1
P value GO categories Count/
Expected count
P value
Enriched in degenerative embryos2 Biological process
Nuclear receptors 23/40 <0.001 Cholesterol metabolic process 10/1.4 <0.001
Monoamine GPCRs 20/33 <0.001 Steroid biosynthetic process 8/1.5 <0.001
Cell communication 76/138 <0.001 Small GTPase mediated signal transduction 18/8.3 <0.001
GPCRs class A rhodopsin like 78/185 <0.001 Cellular component
Cytokine pathway 18/22 0.003 Endoplasmic reticulum membrane 18/8.4 0.002
Enriched in normal embryos3 Molecular function
Biosynthesis of steroids 19/24 <0.001 Transferase activity, transferring alkyl or aryl groups 6/1.4 0.002
Met pathway 28/36 0.003
N-glycan biosynthesis 34/42 0.005
Linoleic acid metabolism 17/31 0.011
1 n = number of genes in the analyzed dataset; m = number of genes in the original gene set
2 Enrichment in degenerative embryo means significantly more genes in this gene set showed higher expression in degenerative embryos
3 Enrichment in blastocysts means significantly more genes in this gene set showed higher expression in blastocysts
Huang et al. BMC Genomics 2010, 11:23
http://www.biomedcentral.com/1471-2164/11/23
Page 7 of 11
Importantly, the results presented provide useful infor-
mation in conceiving future experiments aiming at the
mechanistic understanding of early embryonic develop-
ment as well as improving current assisted reproductive
technology. There is a growing body of studies reporting
the use of the bovine as a suitable model for human
infertility and embryonic development [3,4]. As such,
genes and pathways associated with early embryonic
development identified in this study can be utilized to
investigate similar traits in other mammalian species.
Methods
In vitro fertilization and sample preparation
Ovaries from mature cows were collected at a local
abattoir and immediately followed by aspiration of
oocytes from antral follicles (> 2-6 mm). Oocytes were
processed, incubated in maturation media, and allowed
to mature for 24 hours. Mature oocytes were combined
with bull semen adjusted to a final concentration of 1 ×
106/mL sperm. Frozen thawed bull semen was Percoll
separated as described previously [35] using a discontin-
ued 45%-95% gradient. Putative zygotes were cultured
for 120 hours (5 days) before they were evaluated for
evidence of compaction or cell coalescence. On day 5 of
development in vitro (fertilization = day 0) embryos
were viewed via light microscopy to assess morphologi-
cal development (Figure 1). Embryos that exhibited
compaction (cellular coalescence) were classified as
compacted morula. Embryos that have not attained 16-
32 cells and that did not exhibit compaction were classi-
fied as early degenerate. Early degenerative embryos
might include a range of cellular development from 2
cell (initial cleavage) up to 8-16 non-compacting cells
and were removed from the culture and excluded from
further analysis. Embryos showing evidence of compac-
tion were cultured for additional 72 hours (day 8 of
development) until they were morphologically graded as
blastocysts or degenerative. On day 8, embryos exhibit-
ing a distinct inner cell mass and obvious blastocoele
were classified as blastocysts. Embryos that did not
properly transition from morula to blastocyst were clas-
sified as late degenerative embryos (Figure 1). These two
groups of embryos were subjected to microarray and
subsequent analysis. Blastocysts and late degenerative
embryos were collected and stored in RNAlater
(Ambion, TX) to preserve RNA integrity. Embryo cul-
ture conditions and media were as described [10].
Briefly, putative zyotes were cultured in syntheic oviduc-
tal fluid (Biowhittaker, Walkersburg, MD) supplemented
with 0.22 mM sodium pyruvate, 25 ug/mL gentamicin
sulfate and 8 mg/mL essentially fatty acid-free BSA.
Three pools consisting of 20 randomly sampled blasto-
cysts or degenerative embryos were created. Embryos
were produced from 5 bulls and 57 cows. Each pool
contained embryos from 5 - 12 cows and 3 - 5 bulls.
Total RNA was extracted from pools of embryos using
RNaqueous Micro (Ambion, TX) and quality controlled
using a RNA6000 PicoChip (Agilent Technologies, CA).
The PicoChip was analyzed on an Agilent 2100 Bioana-
lyzer (Additional file 2) according to manufacturer’s
instructions. Approximately 100 ng of total RNA was
purified from a pool 20 embryos.
Linear amplification and labeling of complementary
RNA (cRNA)
Due to the limited amount of RNA present in embryos,
a two-round linear amplification was employed to
amplify and label whole polyadenylated pools of RNA
[11] using the MessageAmp II aRNA amplification kit
(Ambion, TX). Briefly, the first round of amplification
was achieved by priming cDNA synthesis with a T7 pro-
moter tagged poly-dT primer and in vitro transcription
by T7 polymerase with unlabeled NTPs. Purified first-
round aRNA was quality checked and then subjected to
the second round amplification and labeling with biotin-
lyted UTP following manufacturer’s protocol. In fact, for
all Affymetrix arrays this second round of amplification
and labeling must be performed, and total RNA is used
as input [12].
Array hybridization and data acquisition
A total of 15 ug of the biotin-labeled cRNA was frag-
mented and hybridized to GeneChip Bovine Genome
Array (Affymetrix, CA). After staining and washing,
microarrays were scanned using a GC3000 7G scanner
at the University of Wisconsin Biotechnology Center
Gene Expression Center. Raw data was acquired by
GeneChip® Operating Software v1.4 (GCOS) and stored
as .CEL files. Data from Kues et al. [6] was downloaded
from GEO database at NCBI with the accession number
GSE12327 as .CEL files.
Analysis of microarray data
All data analysis was carried out using Bioconductor 2.3
[36] packages implemented with R 2.8.1 [37]. Microarray
expression intensities were preprocessed using the
‘GCRMA’ (v2.14.1) [38] package in Bioconductor, which
corrected backgrounds based on calculated affinities of
probe sequences, quantile-quantile normalized intensi-
ties, and summarized expressions of probe sets through
median-polish and log2 transformed expression values.
MAS5 detection calls [39] were used to qualitatively
classify transcript presence. Transcripts that were called
“P” (present) in at least two out of the three samples
were classified as “Expressed” whereas transcripts called
“A” (Absent) in all three samples were classified as “Not
expressed”. Unclassified transcripts represented genes
whose expressions were at the detection limit or at
extremely low levels.
There are a total of 24,128 probe sets on the Bovine
Genome Array. Probe sets that represent spike-in
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controls or did not vary across all samples were removed,
leaving a total of 18,946 probe sets. Significance Analysis
of Microarrays (SAM) [40] was used to identify differen-
tially-expressed probe sets by the ‘siggenes’ (v1.16.0)
package in Bioconductor, with the False Discovery Rate
(FDR) controlled at 15%. Differentially-expressed genes
were hierarchically clustered and visualized using func-
tions from the ‘gplots’ (v2.6.0) package in R.
Gene Set Enrichment Analysis (GSEA) [17] was car-
ried out using a desktop version of GSEA which queried
‘canonical pathways’ (v2.5) in the MsigDB database
http://www.broad.mit.edu/gsea/msigdb/index.jsp. It is a
collection of 649 gene sets curated from various sources
including KEGG, GenMAPP, and gene ontology among
others. Gene sets were permuted 5000 times to estimate
FDRs for enrichments. In addition, 352 unique differen-
tially-expressed Entrez genes having gene ontology (GO)
annotations were identified by setting FDR to 25% in
SAM. Enrichments for GO terms were tested by a
hypergeometric test (‘GOstats’ package v2.8.0) with
respect to 6598 unique GO annotated Entrez genes on
the bovine array. Hypergeometric p values were cor-
rected using the Benjamini-Hochberg method [41] to
control FDR at 0.25 for GO enrichments. Two addi-
tional filters were applied to minimize false positives:
1) GO categories with fewer than 20 genes were
dropped; 2) when a significant GO category is a parent
of (contains) another significant GO category, only the
child was considered. Enrichments with FDR = 0.25 [42]
were presented.
Real-time RT-PCR
To validate results obtained by microarrays, nine genes
(PHLDA2, FERMT2, RP2, SHISA2, MCF2L, TGFBR3,
SLC11A2, SERPINC1, FDFT1) found differentially
expressed by microarrays were tested using real-time
RT-PCR. Genes were chosen to represent a wide range
of fold changes. FERMT2, SHISA2, TGFBR3, SLC11A2,
SERPINC1, and FDFT1 were changed between two- and
four-fold. RP2 and MCF2L were changed between
four- and eight-folds. And PHLDA2 was changed over
eight-fold. Five additional pools of blastocysts and
degenerative embryos were constructed from which
RNA was extracted as described above. cDNA was
synthesized from first round aRNA in the microarray
experiment and the independent mRNA samples using
the iScript cDNA synthesis kit (Bio-Rad Laboratories,
CA). Dilutions of cDNA were used as template for real-
time PCR using iQ SYBR Green Supermix (Bio-Rad
Laboratories, CA). The reference gene GAPDH was
amplified as an endogenous control. Importantly, the
expression of GAPDH on microarrays was largely invari-
able across samples. To establish the stability of
GAPDH, two additional reference gene RPLP0 (riboso-
mal protein large P0) and ACTB (actin, beta) were
chosen and stability of GAPDH was M = 0.4 as calcu-
lated using the Vandesompele method [43]. To achieve
sufficient biological replication of samples, the genes
were divided into two groups and tested separately
using different sources of RNA. For PHLDA2, FERMT2,
RP2, and SHISA2, three aRNA samples used for micro-
array and two independent mRNA pools were tested for
each of blastocysts and degenerative embryos (Addi-
tional file 1). For the remaining five genes, three differ-
ent mRNA pools were tested for each of blastocysts and
degenerative embryos (Additional file 1). Relative gene
expressions were calculated using the 2-ΔΔCt method
[44]. All primers used are listed in Table 3.
Additional file 1: RNA extracted/amplified from pools of embryos
and RNA used for real time RT-PCR. Sources of RNA used for the real
time RT-PCR validation of microarray results.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2164-11-
23-S1.DOC ]
Additional file 2: Representative gel like images of RNA from
blastocysts and degenerative embryos. Two representative images of
RNA extracted from blastocyst and degenerative embryos. The RNA was
analyzed by a RNA6000 PicoChip on BioAnalyzer 2001.
Click here for file
[ http://www.biomedcentral.com/content/supplementary/1471-2164-11-
23-S2.PDF ]
Table 3 Primer sequences in real- time RT-PCR reactions
and products’ sizes
Gene Primer Sequence (5' - 3') Amplicon
(bp)
GAPDH Forward TGCCCAGAATATCATCCC 134
Reverse AGGTCAGATCCACAACAG
PHLDA2 Forward CCTAAGTCCCACGGCGAATC 109
Reverse CTATATCCTTGCCCTGGTCAGC
FERMT2 Forward GATTAGGATGGACGCCAGCAC 128
Reverse AGGACAACCGTACTTCATCTGC
SHISA2 Forward GCGGCTGCGACAACGATC 130
Reverse ATGAAGGCGACAAACACTGACC
RP2 Forward AAGCACCTGACTTCCTTCCTC 119
Reverse CTTGGTCCCTTTGAATGTCTCG
TGFBR3 Forward TCGCTGGATGCCTCAATG 140
Reverse ATCTGTGGAGTAATTGGAATCG
MCF2L Forward TGAGCCTGGAGGGATACG 110
Reverse GCCATCGTTGTCCTCAGG
SLC11A2 Forward TGCAGTGGTCAGCGTAGC 111
Reverse TTAGAGATGCTTACCGTGTGC
SERPINC1 Forward AAGTCCAGGCTCCCAGGTATTG 142
Reverse GCGAACGACCAGCGATGC
FDFT1 Forward GGTCACCCTGATGATGGATGC 139
Reverse CCTGATGGTGGAGATGATCTGC
ACTB Forward AGGCCAACCGTGAGAAGATGAC 100
Reverse CCAGAGGCATACAGGGACAGC
RPLP0 Forward GACAATGGCAGCATCTAC 198
Reverse GAAGGTGTAATCAGTCTC
Huang et al. BMC Genomics 2010, 11:23
http://www.biomedcentral.com/1471-2164/11/23
Page 9 of 11
Acknowledgements
This study was supported by USDA Hatch grant No. WIS-142-PRJ16JH from
the University of Wisconsin-Madison. The authors thank Ricky Monson and
Ashley Driver for assistance with the IVF experiments.
Author details
1Department of Dairy Science, University of Wisconsin-Madison, Madison,
WI 53706, USA. 2Departments of Statistics, Horticulture and Biostatistics
Medical Informatics, University of Wisconsin-Madison, Madison, WI 53706, USA.
Authors’ contributions
WH and HK designed the study and wrote the manuscript. WH performed
the microarray and real-time PCR experiments. WH and BY analyzed the
data. All authors read and approved the final paper.
Received: 24 April 2009
Accepted: 11 January 2010 Published: 11 January 2010
References
1. Royal MD, Smith RF, Friggens NC: Fertility in dairy cows: bridging the
gaps. Animal 2008, 2(08):1101-1103.
2. Diskin MG, Murphy JJ, Sreenan JM: Embryo survival in dairy cows managed
under pastoral conditions. Anim Reprod Sci 2006, 96(3-4):297-311.
3. Wrenzycki C, Herrmann D, Keskintepe L, Martins AJr, Sirisathien S, Brackett B,
Niemann H: Effects of culture system and protein supplementation on
mRNA expression in pre-implantation bovine embryos. Hum Reprod 2001,
16(5):893-901.
4. Menezo YJ, Herubel F: Mouse and bovine models for human IVF. Reprod
Biomed Online 2002, 4(2):170-175.
5. Misirlioglu M, Page GP, Sagirkaya H, Kaya A, Parrish JJ, First NL, Memili E:
Dynamics of global transcriptome in bovine matured oocytes and
preimplantation embryos. Proc Natl Acad Sci USA 2006, 103(50):18905-18910.
6. Kues WA, Sudheer S, Herrmann D, Carnwath JW, Havlicek V, Besenfelder U,
Lehrach H, Adjaye J, Niemann H: Genome-wide expression profiling
reveals distinct clusters of transcriptional regulation during bovine
preimplantation development in vivo. Proc Natl Acad Sci USA 2008,
105(50):19768-19773.
7. Corcoran D, Fair T, Park S, Rizos D, Patel OV, Smith GW, Coussens PM,
Ireland JJ, Boland MP, Evans AC, et al: Suppressed expression of genes
involved in transcription and translation in in vitro compared with in
vivo cultured bovine embryos. Reproduction 2006, 131(4):651-660.
8. Khatib H, Huang W, Wang X, Tran AH, Bindrim AB, Schutzkus V, Monson RL,
Yandell BS: Single gene and gene interaction effects on fertilization and
embryonic survival rates in cattle. J Dairy Sci 2009, 92(5):2238-2247.
9. Khatib H, Maltecca C, Monson RL, Schutzkus V, Wang X, Rutledge JJ: The
fibroblast growth factor 2 gene is associated with embryonic mortality
in cattle. J Ani Sci 2008, 86(9):2063-2067.
10. Khatib H, Monson RL, Schutzkus V, Kohl DM, Rosa GJ, Rutledge JJ:
Mutations in the STAT5A gene are associated with embryonic survival
and milk composition in cattle. J Dairy Sci 2008, 91(2):784-793.
11. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine
JH: Amplified RNA synthesized from limited quantities of heterogeneous
cDNA. Proc Natl Acad Sci USA 1990, 87(5):1663-1667.
12. Affymetrix Inc: GeneChip® Expression Analysis. Santa Clara, CA: Affymetrix
Inc 2004.
13. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display
of genome-wide expression patterns. Proc Natl Acad Sci USA 1998,
95(25):14863-14868.
14. Shi X, Ma YQ, Tu Y, Chen K, Wu S, Fukuda K, Qin J, Plow EF, Wu C: The
MIG-2/integrin interaction strengthens cell-matrix adhesion and
modulates cell motility. J Biol Chem 2007, 282(28):20455-20466.
15. Kooistra MR, Dube N, Bos JL: Rap1: a key regulator in cell-cell junction
formation. J Cell Sci 2007, 120(Pt 1):17-22.
16. Bos JL: Linking Rap to cell adhesion. Curr Opin Cell Biol 2005, 17(2):123-128.
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment
analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550.
18. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN: On the utility of
pooling biological samples in microarray experiments. Proc Natl Acad Sci
USA 2005, 102(12):4252-4257.
19. Puskas LG, Zvara A, Hackler LJr, Van Hummelen P: RNA amplification
results in reproducible microarray data with slight ratio bias.
Biotechniques 2002, 32(6):1330-1340.
20. Lee MP, Feinberg AP: Genomic imprinting of a human apoptosis gene
homologue, TSSC3. Cancer Res 1998, 58(5):1052-1056.
21. Zaitoun I, Khatib H: Assessment of genomic imprinting of SLC38A4,
NNAT, NAP1L5, and H19 in cattle. BMC Genetics 2006, 7:49.
22. Dindot SV, Kent KC, Evers B, Loskutoff N, Womack J, Piedrahita JA:
Conservation of genomic imprinting at the XIST, IGF2, and GTL2 loci in
the bovine. Mamm Genome 2004, 15(12):966-974.
23. Qian N, Frank D, O’Keefe D, Dao D, Zhao L, Yuan L, Wang Q, Keating M,
Walsh C, Tycko B: The IPL gene on chromosome 11p15.5 is imprinted in
humans and mice and is similar to TDAG51, implicated in Fas
expression and apoptosis. Human Mol Genet 1997, 6(12):2021-2029.
24. Salas M, John R, Saxena A, Barton S, Frank D, Fitzpatrick G, Higgins MJ,
Tycko B: Placental growth retardation due to loss of imprinting of
Phlda2. Mech Dev 2004, 121(10):1199-1210.
25. Frank D, Fortino W, Clark L, Musalo R, Wang W, Saxena A, Li CM, Reik W,
Ludwig T, Tycko B: Placental overgrowth in mice lacking the imprinted
gene Ipl. Proc Natl Acad Sci USA 2002, 99(11):7490-7495.
26. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998, 67:
753-791.
27. Jones RL, Stoikos C, Findlay JK, Salamonsen LA: TGF-beta superfamily
expression and actions in the endometrium and placenta. Reproduction
2006, 132(2):217-232.
28. Wei CJ, Xu X, Lo CW: Connexins and cell signaling in development and
disease. Annu Rev Cell Dev Biol 2004, 20:811-838.
29. Boni R, Tosti E, Roviello S, Dale B: Intercellular communication in in vivo- and
in vitro-produced bovine embryos. Biol Reprod 1999, 61(4):1050-1055.
30. Paria BC, Sengupta J, Manchanda SK: Role of embryonic oestrogen in
rabbit blastocyst development and metabolism. J Reprod Fertil 1984,
70(2):429-436.
31. Niemann H, Elsaesser F: Evidence for estrogen-dependent blastocyst
formation in the pig. Biol Reprod 1986, 35(1):10-16.
32. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel
DP: The widespread impact of mammalian MicroRNAs on mRNA
repression and evolution. Science 2005, 310(5755):1817-1821.
33. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel
DP, Linsley PS, Johnson JM: Microarray analysis shows that some
microRNAs downregulate large numbers of target mRNAs. Nature 2005,
433(7027):769-773.
34. Smith SL, Everts RE, Sung LY, Du F, Page RL, Henderson B, Rodriguez-Zas
SL, Nedambale TL, Renard JP, Lewin HA, et al: Gene expression profiling of
single bovine embryos uncovers significant effects of in vitro
maturation, fertilization and culture. Mol Reprod Dev 2009, 76(1):38-47.
35. Parrish JJ, Krogenaes A, Susko-Parrish JL: Effect of bovine sperm separation
by either swim-up or Percoll method on success of in vitro fertilization
and early embryonic development. Theriogenology 1995, 44(6):859-869.
36. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B,
Gautier L, Ge Y, Gentry J, et al: Bioconductor: open software development
for computational biology and bioinformatics. Genome Biol 2004, 5(10):
R80.
37. R Development Core Team: R: A Language and Environment for
Statistical Computing. Vienna, Austria: R Foundation for Statistical
Computing 2008.
38. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F: A Model-
Based Background Adjustment for Oligonucleotide Expression Arrays.
J Amer Stat Assoc 2004, 99:909-917.
39. Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, Webster TA, Harrington
CA, Ho MH, Baid J, et al: Analysis of high density expression microarrays
with signed-rank call algorithms. Bioinformatics 2002, 18(12):1593-1599.
40. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001,
98(9):5116-5121.
41. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: a Practical
and Powerful Approach to Multiple Testing. J R Statist Soc B 1995, 57:963-
971.
Huang et al. BMC Genomics 2010, 11:23
http://www.biomedcentral.com/1471-2164/11/23
Page 10 of 11
42. Goeman JJ, Buhlmann P: Analyzing gene expression data in terms of
gene sets: methodological issues. Bioinformatics 2007, 23(8):980-987.
43. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A,
Speleman F: Accurate normalization of real-time quantitative RT-PCR
data by geometric averaging of multiple internal control genes. Genome
Biol 2002, 3(7):RESEARCH0034.
44. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
2001, 25(4):402-408.
doi:10.1186/1471-2164-11-23
Cite this article as: Huang et al.: Transcriptomic profiling of bovine IVF
embryos revealed candidate genes and pathways involved in early
embryonic development. BMC Genomics 2010 11:23.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Huang et al. BMC Genomics 2010, 11:23
http://www.biomedcentral.com/1471-2164/11/23
Page 11 of 11
